Biotech Cellexus doubling up with Dundee base and new hires
The firm has added a new lease to its office locations, taking an adjoining unit at Mayo Avenue in the city.
On the personnel front, it has welcomed Adam Ostrowski to a newly created technical application specialist role. With a background in microbiology, Ostrowski will focus on supporting new and existing customers.
Meanwhile, Craig Walker has also joined the technical team, increasing the firm’s in-house production capabilities.
The bioreactor manufacturer has set its sights on growing its team further, with plans to hire within its technical, sales, marketing and administration functions.
With a recently closed share round, the firm now has the funding required for further product development, with plans for bioreactors with smaller and larger working volumes in the pipeline.
A spokeswoman for the company said: “It is a very exciting time for Cellexus. Our expanding product range will allow us to approach new markets and new sectors, while continuing to bring the very best solutions to our customers.
“We are also looking forward to bringing new talent, knowledge and experience into the team based here in Dundee.”
Cellexus International was formed in 2017 to research, develop and manufacture the CellMaker range of “revolutionary single-use, airlift bioreactor systems” and related technology.
A message from the Editor:
Thank you for reading this story on our website. While I have your attention, I also have an important request to make of you.
The dramatic events of 2020 are having a major impact on many of our advertisers - and consequently the revenue we receive. We are now more reliant than ever on you taking out a digital subscription to support our journalism.
Subscribe to scotsman.com and enjoy unlimited access to Scottish news and information online and on our app. Visit https://www.scotsman.com/subscriptions now to sign up.
By supporting us, we are able to support you in providing trusted, fact-checked content for this website.
Want to join the conversation? Please or to comment on this article.